Lv1
38 积分 2023-12-07 加入
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
6小时前
待确认
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
6小时前
已完结
Downregulation of Wtap causes dilated cardiomyopathy and heart failure
1年前
已完结
Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium–Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials
1年前
已完结
Chapter 3: Clinical Trials of Sodium-Glucose Co-Transporter-2 Inhibitors for Treatment of Heart Failure
1年前
已完结
Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on serum uric acid level: A meta-analysis of randomized controlled trials
1年前
已完结
Serum uric acid lowering with empagliflozin in heart failure with reduced ejection fraction: a sweet added benefit?
1年前
已完结
Short-term Changes in Hemoglobin and Changes in Functional Status, Quality of Life and Natriuretic Peptides After Initiation of Dapagliflozin in Heart Failure With Reduced Ejection Fraction
1年前
已完结
Sodium-Glucose Cotransporter 2 Inhibitors and Cardiac Remodeling
1年前
已完结
Performance of sodium-glucose cotransporter 2 inhibitors in cardiovascular disease
1年前
已完结
皖公网安备34019202002308
